Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Beca, J
846  Ergebnisse:
Personensuche X
?
1

Outcomes Following Treatment with FOLFOX for Patients with ..:

Habbous, S. ; Tai, X. ; Gill, T....
Clinical Oncology.  35 (2023)  3 - p. 188-198 , 2023
Link: https://doi.org/10.1016/..
 
?
2

HPR161 International Comparisons of Health Technology Asses..:

Beca, J. ; Scott, K. ; Gosselin, S....
Value in Health.  26 (2023)  6 - p. S238 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Impact of a Novel Prioritization Framework on Clinician-Led..:

Keech, J. ; Beca, J. ; Eisen, A....
Current Oncology.  26 (2019)  2 - p. 155-161 , 2019
Link: https://doi.org/10.3747/..
 
?
4

PCN60 FITTING DISTRIBUTIONS OF PARAMETRIC MODELS INTO NON-P..:

Djalalov, S. ; Beca, J. ; Ewara, E..
Value in Health.  22 (2019)  - p. S67 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Abstract PD-046: THE USE OF NEUROMONITORING DURING ECMO TO ..:

Ganeshalingham, A. ; Nita, D. ; Delama Caro-Paton, G....
Pediatric Critical Care Medicine.  19 (2018)  6S - p. 44-44 , 2018
Link: https://doi.org/10.1097/..
 
?
6

Cost-effectiveness of pazopanib: an example of improved tra..:

Beca, J. ; Chan, K.K.W.
Current Oncology.  23 (2016)  4 - p. 327 , 2016
Link: https://doi.org/10.3747/..
 
?
7

Estimating the Costs of Intensity-Modulated and 3-Dimension..:

Yong, J.H.E. ; McGowan, T. ; Redmond-Misner, R....
Current Oncology.  23 (2016)  3 - p. 228-238 , 2016
Link: https://doi.org/10.3747/..
 
?
8

Cost-Effectiveness of Pazopanib: An Example of Improved Tra..:

Beca, J. ; Chan, K.K.W.
Current Oncology.  23 (2016)  4 - p. 327-329 , 2016
Link: https://doi.org/10.3747/..
 
?
9

Economic Evaluation of Hormonal Therapies for Postmenopausa..:

Djalalov, S. ; Beca, J. ; Amir, E....
Current Oncology.  22 (2015)  2 - p. 84-96 , 2015
Link: https://doi.org/10.3747/..
 
?
10

Fulminant myocarditis:

Park, K. ; Beca, J. ; McKee, A....
Heart, Lung and Circulation.  23 (2014)  - p. e35-e36 , 2014
Link: https://doi.org/10.1016/..
 
?
11

ABSTRACT 318: A COMPARISON BETWEEN TWO NEAR-INFRARED SPECTR..:

Ganeshalingham, A. ; Beca, J.
Pediatric Critical Care Medicine.  15 (2014)  - p. 74 , 2014
Link: https://doi.org/10.1097/..
 
?
12

The Cost-Effectiveness of 2nd Line Crizotinib in EML4-Alk R..:

Djalalov, S. ; Graham, D.M. ; Beca, J....
Value in Health.  17 (2014)  3 - p. A90 , 2014
Link: https://doi.org/10.1016/..
 
?
13

ABSTRACT 635: THE NEW ZEALAND PERTUSSIS EXPERIENCE:

Ganeshalingham, A. ; Anderson, B.A. ; McSharry, B..
Pediatric Critical Care Medicine.  15 (2014)  - p. 143-144 , 2014
Link: https://doi.org/10.1097/..
 
?
14

The Cost-Effectiveness of Second-Line Crizotinib in Eml4-Al..:

Djalalov, S. ; Graham, D.M. ; Beca, J....
Value in Health.  17 (2014)  7 - p. A642 , 2014
Link: https://doi.org/10.1016/..
 
?
15

Exploring the impact of structural uncertainty in partition..:

Beca, J. ; Hoch, J.S.
Value in Health.  17 (2014)  3 - p. A205-A206 , 2014
Link: https://doi.org/10.1016/..
 
1-15